Disease/Infection News

RSS

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevention against the Human Immunodeficiency Virus (HIV). This type of therapeutic vaccine helps the patients who are carriers of the virus, combat infection and control the appearance of AIDS in the same way as with the current antiretroviral treatments.

3 Feb 2011

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Three studies published on Tuesday in PLoS Medicine show that "intermittent use of preventive antimalarial drugs can be beneficial in curbing the spread of the disease in children," Agence France-Presse reports (2/1).

3 Feb 2011

Malaria transmission to decline in Burundi because of global warming

Malaria transmission will not increase because of global warming in the African nation of Burundi according to a statistical analysis by researchers in Austria and Burundi. Writing in the International Journal of Global Warming, the team explains that rising temperatures will lead to lower humidity and rainfall which will shorten the lifespan of mosquitoes carrying malaria.

3 Feb 2011

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the clinical study, SINGLE (ING114467), designed to support a new fixed-dose combination (FDC) therapy for the treatment of HIV.

3 Feb 2011

Fidaxomicin demonstrates 45% reduction in recurrences vs. existing treatment for C. difficile infection

Clostridium difficile infection (CDI) is a significant and growing problem in hospitals and other health care facilities, but no new drugs to treat the condition have been developed in several decades. However, a large-scale, phase 3 trial conducted by Canadian and U.S. researchers shows that the new antibiotic Fidaxomicin is superior to existing treatments, demonstrating a 45 percent reduction in recurrences vs. the existing licensed treatment.

3 Feb 2011

Study finds recurrences of shingles prevalent in the immunocompetent population

For decades, medical wisdom about shingles has been that it's a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published in the February issue of Mayo Clinic Proceedings, recurrences of shingles may be significantly more common than doctors have suspected.

2 Feb 2011

Size of influenza-laden particles linked to risk of infection

A parent's wise advice to never go to a hospital unless you want to get sick may be gaining support from scientific studies on a specific airborne virus.

2 Feb 2011

New study examines role of later acquisition of hepatitis C in HIV patients

Hepatitis C is a leading cause of illness and death for individuals infected with both HIV and hepatitis C. Recent reports from around the world demonstrate that hepatitis C is emerging as a sexually transmitted infection among HIV-infected men who do not inject drugs. However, many HIV-infected men do not receive continued screening for hepatitis C throughout their HIV care.

2 Feb 2011

TEAM TO END AIDS endurance training program launched

AIDS United has officially launched TEAM TO END AIDS, a new endurance training program for all levels of athletes that includes marathon and half marathon coaching. Beginners and experienced athletes can register today at: www.T2EA.com.

2 Feb 2011

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

On the final day of the two-day African Union Summit taking place in Addis Ababa, Ethiopia, U.N. Secretary-General Ban Ki-moon on Monday called for greater efforts to reduce sexual violence, particularly during armed conflicts, Ezega.com reports.

2 Feb 2011

FDA issues reminder about safe use of non-sterile alcohol prep pads

Following a recent recall of potentially contaminated non-sterile alcohol prep pads, the U.S. Food and Drug Administration today reminded health care professionals about the safe use of non-sterile alcohol prep pads to clean and disinfect the surface of the skin.

2 Feb 2011

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

It is estimated that there are more than one million orphans around the world living with HIV/AIDS. Bethany Christian Services, the nation's largest adoption agency, today announced the creation of the HIV Adoption Toolkit for couples considering adopting children living with HIV/AIDS.

2 Feb 2011

New research: HIV-infected youth get pregnant more often, suffer complications frequently

Teenage girls and young women infected with HIV get pregnant more often and suffer pregnancy complications more frequently than their HIV-negative peers, according to new research led by Johns Hopkins investigators.

2 Feb 2011

Surge of mosquito borne disease in South Australia following wet weather

Rising water in the Murray River has caused a surge in mosquito-borne infections in South Australia. The water is rising in the Murray in SA as floodwaters move downstream from the eastern states.

2 Feb 2011

CDH first hospital in New England to use Xenex PX-UV disinfection system

Cooley Dickinson Hospital (CDH) today announced it is the first hospital in New England to use the Xenex PX-UV disinfection system to disinfect its patient and operating rooms.

2 Feb 2011

Daily probiotic may help prevent upper respiratory tract infections in athletes: Research

Researchers at Loughborough University have revealed that a simple, daily probiotic might help prevent athletes catching colds during their training and competition.

2 Feb 2011

Scientists test new dry powder measles vaccine that can be inhaled

Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. A team of researchers, led by scientists at the Johns Hopkins Bloomberg School of Public Health and the University of Colorado, developed and successfully tested a dry powder, live-attenuated measles vaccine that can be inhaled.

2 Feb 2011

Study finds link between oral health care and heart disease

During American Heart Month in February, United Concordia Dental, one of the nation's largest dental insurers, wants to remind adults that taking care of their teeth and gums is an important part of promoting heart health.

2 Feb 2011

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

Medicago, a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate.

1 Feb 2011

Positive interim results from Medicago's Phase II clinical trial of H5N1 Avian Influenza VLP vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

1 Feb 2011

Disease/Infection News

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Malaria transmission to decline in Burundi because of global warming

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Fidaxomicin demonstrates 45% reduction in recurrences vs. existing treatment for C. difficile infection

Study finds recurrences of shingles prevalent in the immunocompetent population

Size of influenza-laden particles linked to risk of infection

New study examines role of later acquisition of hepatitis C in HIV patients

TEAM TO END AIDS endurance training program launched

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

FDA issues reminder about safe use of non-sterile alcohol prep pads

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

New research: HIV-infected youth get pregnant more often, suffer complications frequently

Surge of mosquito borne disease in South Australia following wet weather

CDH first hospital in New England to use Xenex PX-UV disinfection system

Daily probiotic may help prevent upper respiratory tract infections in athletes: Research

Scientists test new dry powder measles vaccine that can be inhaled

Study finds link between oral health care and heart disease

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

Positive interim results from Medicago's Phase II clinical trial of H5N1 Avian Influenza VLP vaccine

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News